Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Cost Effectiveness and Resource Allocation
Published in: Cost Effectiveness and Resource Allocation 1/2014

Open Access 01-12-2014 | Methodology

Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis

Authors: Ole F Norheim, Rob Baltussen, Mira Johri, Dan Chisholm, Erik Nord, DanW Brock, Per Carlsson, Richard Cookson, Norman Daniels, Marion Danis, Marc Fleurbaey, Kjell A Johansson, Lydia Kapiriri, Peter Littlejohns, Thomas Mbeeli, Krishna D Rao, Tessa Tan-Torres Edejer, Dan Wikler

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2014

Login to get access

Abstract

This Guidance for Priority Setting in Health Care (GPS-Health), initiated by the World Health Organization, offers a comprehensive map of equity criteria that are relevant to health care priority setting and should be considered in addition to cost-effectiveness analysis. The guidance, in the form of a checklist, is especially targeted at decision makers who set priorities at national and sub-national levels, and those who interpret findings from cost-effectiveness analysis. It is also targeted at researchers conducting cost-effectiveness analysis to improve reporting of their results in the light of these other criteria.
The guidance was develop through a series of expert consultation meetings and involved three steps: i) methods and normative concepts were identified through a systematic review; ii) the review findings were critically assessed in the expert consultation meetings which resulted in a draft checklist of normative criteria; iii) the checklist was validated though an extensive hearing process with input from a range of relevant stakeholders.
The GPS-Health incorporates criteria related to the disease an intervention targets (severity of disease, capacity to benefit, and past health loss); characteristics of social groups an intervention targets (socioeconomic status, area of living, gender; race, ethnicity, religion and sexual orientation); and non-health consequences of an intervention (financial protection, economic productivity, and care for others).
Literature
1.
World Health Report: Financing for Universal Coverage. Geneva: World Health Organization; 2010.
2.
3.
Sassi F, Archard L, Le Grand J: Equity and the economic evaluation of healthcare. Health Technol Assess 2001, 5: 3.CrossRef
4.
Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Rice N, Sculpher M, Sowden A: Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy 2009,93(2–3):85–92.PubMedCrossRef
5.
Hauck K, Smith PC, Goddard M: The Economics of Priority Setting in Health Care. Washington, D.C., USA: The International Bank for Reconstruction and Development/The World Bank; 2003.
6.
Daniels N: Just Health: Meeting Health Needs Fairly. Cambridge: Cambridge University Press; 2008.
7.
Brock D, Wikler D, et al.: Ethical Issues in Resource Allocation, Research, and New Products Development. In Disease Control Priorities in Developing Countries. 2nd edition. Edited by: Jamison D, Breman J, Measham A. New York: Oxford University Press and the World Bank; 2006.
8.
9.
Nord E: Towards cost-value analysis in health care? Health Care Anal 1999,7(2):167–175. 10.1023/A:1009489122094PubMedCrossRef
10.
Baltussen R, Stolk E, Chisholm D, Aikins M: Towards a multi-criteria approach for priority setting: an application to Ghana. Health Econ 2006,15(7):689–696. 10.1002/hec.1092PubMedCrossRef
11.
Brock DW, et al.: Ethical Issues in the Use of Cost Effectiveness Analysis for the Prioritization of Health Care Resources. In Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Edited by: Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB. Geneva: World Health Organization; 2003:289–312.
12.
Tromp N, Baltussen R: Mapping of multiple criteria for priority setting of health interventions: an aid for decision makers. BMC Health Serv Res 2012, 12: 454. 10.1186/1472-6963-12-454PubMedCentralPubMedCrossRef
13.
Fleurbaey M, Schokkaert E: Equity in health and health care. In Handbook of Health Economics. Edited by: Pauly M, McGuire T, Pita-Barros P. ᅟ: North-Holland; 2011.
14.
Johri M, Norheim OF: Can cost-effectiveness analysis integrate concerns for equity? Systematic review. Int J Technol Assess Health Care 2012,28(2):125–132. 10.1017/S0266462312000050PubMedCrossRef
15.
16.
17.
18.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. New York: Oxford University Press; 2005.
19.
Williams A: Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997,6(2):117–132. 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-BPubMedCrossRef
20.
Culyer AJ, Wagstaff A: Equity and equality in health and health care. J Health Econ 1993,12(4):431–457. 10.1016/0167-6296(93)90004-XPubMedCrossRef
21.
Wagstaff A, van Doorslaer E: Equity in Health Care Finance and Delivery. In Handbook of Health Economics, Volume 1. Edited by: Culyer AJ, Newhouse JP. ᅟ: Elsevier; 2000.
22.
Musgrove P: Public spending on health care: how are different criteria related? Health Policy 1999,47(3):207–223. 10.1016/S0168-8510(99)00024-XPubMedCrossRef
23.
Hontelez J, Lurie M, Bärnighausen T, Bakker R, Baltussen R, Tanser F, Hallett TB, Newell ML, de Vlas SJ: Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med 2013, 10: 10.CrossRef
24.
Baltussen R, Mikkelsen E, Tromp N, Hurtig A, Byskov J, Olsen Ø, Bærøe K, Hontelez JA, Singh J, Norheim OF: Balancing efficiency, equity and feasibility of HIV treatment in South Africa – development of programmatic guidance. Cost Eff Resour Alloc 2013,11(1):26. 10.1186/1478-7547-11-26PubMedCentralPubMedCrossRef
25.
Dolan P, Shaw R, Tsuchiya A, Williams A: QALY maximisation and people’s preferences: a methodological review of the literature. Health Econ 2005,14(2):197–208. 10.1002/hec.924PubMedCrossRef
26.
Nord E, Pinto JL, Richardson J, Menzel P, Ubel P: Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999,8(1):25–39. 10.1002/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-HPubMedCrossRef
27.
Daniels N: Four unsolved rationing problems. A challenge. Hastings Cent Rep 1994,24(4):27–29. 10.2307/3562841PubMedCrossRef
28.
Brock D: Priority to the Worse Off in health-Care Resource Prioritization. In Medicine and Social Justice. Edited by: Rhodes R, Battin M, Silvers A. Oxford: Oxford University Press; 2002:362–372.
29.
Ottersen T: Lifetime QALY prioritarianism in priority setting. J Med Ethics 2013,39(3):175–180. 10.1136/medethics-2012-100740PubMedCrossRef
30.
Norheim OF: Clinical priority setting. BMJ 2008, 337: a1846. doi:10.1136/bmj.a1846 10.1136/bmj.a1846PubMedCrossRef
31.
National Institute of Health and Clinical Excellence: Infliximab (review) and adalimumab for the treatment of Crohn’s disease. May 2010. London: National Institute of Health and Clinical Excellence; 2010.
32.
Nord E: Cost-Value Analysis in Health Care: Making Sense Out of QALYs. New York: Cambridge University Press; 1999.
33.
Caro J, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P: The efficiency frontier approach to economic evaluation of health-care interventions. Health Econ 2010,19(10):1117–1127. 10.1002/hec.1629PubMedCrossRef
34.
Brock D: Ethical Issues in Recipient Selection for Organ Transplantation. In Organ Substitution Technology. Edited by: Matthieu D. Boulder CO: Westview Press; 1988.
35.
Norheim OF, Asada Y: The ideal of equal health revisited: definitions and measures of inequity in health should be better integrated with theories of distributive justice. Int J Equity Health 2009, 8: 40. 10.1186/1475-9276-8-40PubMedCentralPubMedCrossRef
36.
37.
38.
Marmot M, Allen J, Goldblatt P, Boyce T, McNeish D, Grady M, Geddes I: Fair Society, Healthy Lives: the Marmot Review. London: Ministry of Health UK; 2010.
39.
Marmot M, Friel S, Bell R, Houweling TA, Taylor S: Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 2008,372(9650):1661–1669. 10.1016/S0140-6736(08)61690-6PubMedCrossRef
40.
Daniels N, Kennedy B, Kawachi I: Why justice is good for our health: the social determinants of health inequalities. Daedalus 1999,128(4):215–251.PubMed
41.
Lindholm L, Rosen M: On the measurement of the nation's equity adjusted health. Health Econ 1998,7(7):621–8. 10.1002/(SICI)1099-1050(1998110)7:7<621::AID-HEC370>3.0.CO;2-YPubMedCrossRef
42.
Daniels N: Fair process in patient selection for antiretroviral treatment in WHO’s goal of 3 by 5. Lancet 2005,366(9480):169–171. 10.1016/S0140-6736(05)66518-XPubMedCrossRef
43.
Baltussen R, Johri M, Norheim OF: Fairness in service choice: an important yet underdeveloped path to universal coverage. Trop Med Int Health 2010,16(17):838–839.
44.
Fleurbaey M, Luchini S, Muller C, Schokkaert E: Equivalent incomes and the economic evaluation of health care. Health Econ 2013, 22: 711–729. 10.1002/hec.2859PubMedCrossRef
45.
Murray C: Rethinking DALYs. In The Global Burden of Disease. Edited by: Murray C, Lopez A. Cambridge Mass: Harvard School of Public Health, WHO, World Bank; 1996:1–98.
46.
Murray CJ, Acharya AK: Understanding DALYs (disability-adjusted life years). J Health Econ 1997,16(6):703–730. 10.1016/S0167-6296(97)00004-0PubMedCrossRef
47.
48.
McPake B: User charges for health services in developing countries: a review of the economic literature. Soc Sci Med 1993,36(11):1397–1405. 10.1016/0277-9536(93)90382-EPubMedCrossRef
49.
Hauck K, Smith P, Goddard M: The Economics of Priority Setting for Health: a Literature Review. Washington DC: The World Bank; 2002.
50.
Smith P: Incorporating financial protection into decision rules for publicly financed healthcare treatments. Health Econ 2013, 22: 180–193. 10.1002/hec.2774PubMedCrossRef
51.
Smith P: User charges and priority setting in health care: balancing equity and efficiency. J Health Econ 2005, 24: 1018–1029. 10.1016/j.jhealeco.2005.01.003PubMedCrossRef
52.
Teerawattananon Y, Mugford M, Tangcharoensathien V: Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value in health 2007,10(1):61–72. 10.1111/j.1524-4733.2006.00145.xPubMedCrossRef
53.
Daniels N, Sabin JE: Setting Limits Fairly: Can We Learn to Share Medical Resources?. 2nd edition. Oxford: Oxford University Press; 2008.
54.
Youngkong S, Kapiriri L, Baltussen R: Setting priorities for health interventions in developing countries: a review of empirical studies. Trop Med Int Health 2009,14(8):930–939. 10.1111/j.1365-3156.2009.02311.xPubMedCrossRef
55.
Youngkong S, Baltussen R, Tantivess S, Mohara A, Teerawattananon Y: Multicriteria decision analysis for including health interventions in the Universal Health coverage benefit package in Thailand. Value Health 2012, 15: 961–970. 10.1016/j.jval.2012.06.006PubMedCrossRef
56.
James C, Carrin G, Savedoff W, Hanvoravongchai P: Clarifying efficiency-equity tradeoffs through explicit criteria, with a focus on developing countries. Health Care Anal 2005,13(1):33–51. 10.1007/s10728-005-2568-2PubMedCrossRef
57.
National Institute for Health and Clinical Excellence: Value Based Assessment of Health Technologies. London: NICE; 2014.
58.
Verguet S, Laxminarayan R, Jamison DT: Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost-Effectiveness Analysis. Disease Control Priorities in Developing Countries. Health Econ ᅟ, ᅟ: ᅟ. 2014 Feb 4. doi:10.1002/hec.3019
59.
Littlejohns P, Weale A, Chalkidou K, Faden R, Teerawattananon Y: Social values and health policy: a new international research programme. J Health Organ Manag 2012,26(3):285–292. 10.1108/14777261211238945PubMedCrossRef
60.
Tanios N, Wagner M, Tony M, Baltussen R, van Til J, Rindress D, Kind P, Goetghebeure M: Which criteria should be considered in health care decisions? Insights from an international survey of policy and clinical decisopn makers. Int J Techn Assessment 2013. 2013 (in press)
61.
Golan O, Hansen P, Kaplan G, Tal O: Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights? Health Policy 2011,102(2–3):126–135.PubMedCrossRef
62.
Persad G, Wertheimer A, Emanuel EJ: Principles for allocation of scarce medical interventions. Lancet 2009,373(9661):423–431. 10.1016/S0140-6736(09)60137-9PubMedCrossRef
63.
Kerstein SJ, Bognar G: Complete lives in the balance. Am J Bioeth 2010,10(4):37–45. 10.1080/15265160903581718PubMedCrossRef
64.
65.
Daniels N: Democratic Equality: Rawls’s Complex Egalitarianism. In The Cambridge Companion to Rawls. Edited by: Freeman S. Cambridge: Cambridge University Press; 2003:241–276.
66.
Daniels N: Social and Individual Responsibility for Health. In Distributive Justice and Responsibility. Edited by: Knight C, Stemplowska Z. Oxford and New York: Oxford University Press; 2011:266–287.CrossRef
67.
Wikler D: Personal and Social Responsibility for Health. In Public Health, Ethics, and Equity. Edited by: Anand S, Peter F, Sen AK. Oxford: Oxford University Press; 2004:109–134.
68.
Marchand S, Wikler D, Landesman B: Class, health and justice. Milbank Mem Fund Q 1998,76(3):449–467.CrossRef
Metadata
Title
Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis
Authors
Ole F Norheim
Rob Baltussen
Mira Johri
Dan Chisholm
Erik Nord
DanW Brock
Per Carlsson
Richard Cookson
Norman Daniels
Marion Danis
Marc Fleurbaey
Kjell A Johansson
Lydia Kapiriri
Peter Littlejohns
Thomas Mbeeli
Krishna D Rao
Tessa Tan-Torres Edejer
Dan Wikler
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2014
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-12-18

Other articles of this Issue 1/2014

Cost Effectiveness and Resource Allocation 1/2014 Go to the issue

Research

System dynamics model of cervical cancer vaccination and screening interventions in Kenya

Research

Lifetime QALY prioritarianism in priority setting: quantification of the inherent trade-off

Research

Budget constraint and vaccine dosing: a mathematical modelling exercise

Research

Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece

Research

Do the Washington Panel recommendations hold for Europe: investigating the relation between quality of life versus work-status, absenteeism and presenteeism

Research

Cost-effectiveness of community vegetable gardens for people living with HIV in Zimbabwe